Evidence map›Paper›PMID 34830454›Full record

ArticleInternational journal of molecular sciences2021

Humaira Noor, Ashraf Zaman, Charles Teo, Michael E Sughrue

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. ASPORIN: A root of the matter in tumors and their host environment.Biochimica et biophysica acta. Reviews on cancer · 2024
    Review
  5. Article
  6. Article
  7. Small Leucine-Rich ProteoglycanCurrent issues in molecular biology · 2023
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Humaira NoorCure Brain Cancer Biomarkers and Translational Research Group, Prince of Wales Clinical School, University of New South Wales, Sydney, NSW 2031, Australia.
Ashraf ZamanFaculty of Medicine, University of New South Wales, Randwick, NSW 2031, Australia.
Charles TeoCentre for Minimally Invasive Neurosurgery, Prince of Wales Private Hospital, Randwick, NSW 2031, Australia.
Michael E SughrueCentre for Minimally Invasive Neurosurgery, Prince of Wales Private Hospital, Randwick, NSW 2031, Australia.
Prince of Wales Hospital · AUUNSW Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lower-grade glioma (LGG) is a diffuse infiltrative tumor of the central nervous system, which lacks targeted therapy. We investigated the role of

Indexed as

AdolescentAdultAgedAged, 80 and overB7-H1 AntigenBiomarkers, TumorCpG IslandsCTLA-4 AntigenDisease-Free SurvivalDNA MethylationFemaleGene Expression Regulation, NeoplasticGliomaHumansImmune Checkpoint InhibitorsLymphocytes, Tumor-InfiltratingB7-H1 AntigenBiomarkers, TumorCD274 protein, humanCTLA-4 AntigenCTLA4 protein, humanImmune Checkpoint InhibitorspodocalyxinSialoglycoproteinsCpG methylationG-CIMPgliomaimmune checkpoint blockadeimmune infiltrationlow-grade gliomaPODNL1Podocan-like 1

Identifiers

PMID34830454
PMCPMC8625785
OpenAlexW3214937513

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.